Pharmaceuticals Companies sealed in Pakistan for manufacturing Fake Medicines

Following are names & locations of Pharmaceuticals Companies sealed in Pakistan during last three years on account of manufacturing of spurious medicines;

• Everest Pharmaceuticals (Pvt) Limited

Industrial Triangle, Kahuta Road, Islamabad

• Ambro Pharma (Pvt) Limited

Industrial Triangle, Kahuta Road, Islamabad

• Royal Herbal Enterprises Company

Office Baldia Town No. 3 Karachi

Also Read: List of medicines declared spurious in Pakistan

Complaints received from Pharmaceuticals Firms regarding similarity of brand names;

There are approximately 65,000 human medicines registered so far with the Drug Regulatory Authority of Pakistan (DRAP) and in last six months, a total of 61 cases of look-alike/sound-alike brand of medicines i.e. identical packaging designs and color schemes etc were reported to the DRAP.

Complaints received from Pharmaceuticals Firms regarding similarity of packing material;

Procedure for establishment of Pharmaceutical Unit

As many as 74 Licenses have been granted for manufacturing of drugs/medicines to various manufactures in the Country during the last four years.

Procedure for grant of a Drug Manufacturing License under Drug Act 1976;

1. Receipt of application for site verification

• Verification of suitability of site by panel of inspectors for establishment of Pharmaceutical Unit
• Approval of site for establishment of Pharmaceutical Unit

2. Receipt of Layout Plan along with prescribed fee

• Scrutiny and Approval of Layout Plan(s)
• Construction of Factory Premises by applicant

3. Receipt of application for grant of License on Form-I along with requisite document & fee

• Plan Inspection before grant of Drug Manufacturing License (DMD)

4. Consideration of application by Central Licensing Board (CLB) in the light of recommendation of panel.

• Approval for grant of Drug Manufacturing License (DMD) by Central Licensing Board (CLB)
• Issuance of Drug Manufacturing License (DMD) for a period of five years and subsequent renewal for further period of five years

Note: The above data/information was shared by the Minister for National Health Services, Regulations and Coordination with the Senate on January 14, 2020.